Gerardus Johannes van Jeveren
Chief Executive Officer at Fagron GmbH & Co. KG
Profile
Gerardus Johannes van Jeveren is the founder of Fagron Group BV and Fagron GmbH & Co. KG, both founded in 1990.
He held the title of Manager-Business Unit at Fagron Group BV and the title of Chief Executive Officer at Fagron GmbH & Co. KG.
Currently, he is the Director at Pharma Chemicals SA since 2020.
Previously, he was the Chief Executive Officer & Executive Director at Fagron NV from 2007 to 2015.
He was also a Director at Omega Pharma NV from 2001 to 2005 and a Manager-Commercial at Pharbita Generics.
Mr. van Jeveren obtained an undergraduate degree from Lerarenopleiding Zuid West Nederland.
Gerardus Johannes van Jeveren active positions
Companies | Position | Start |
---|---|---|
Fagron GmbH & Co. KG
Fagron GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Fagron GmbH & Co. KG develops and manufactures pharmaceutical products. Its brands include SyrSpend SF, Fitalite, Versatile, Versatile Rich, Nourivan Antiox, Espumil, Latanoprost, Pentravan Transdermale, and CapsiCards System. It also offers pharmaceutical solutions for pharmacies, hospitals, and clinics. The company was founded by Gerardus Johannes van Jeveren in 1990 and is headquartered in Barsbüttel, Germany. | Chief Executive Officer | 1989-12-31 |
Pharma Chemicals SA
Pharma Chemicals SA Pharmaceuticals: MajorHealth Technology Pharma Chemicals SA manufactures pharmaceutical products. The private company is based in Braine-le-Château, Belgium. The Belgian company was founded in 2016. Tieme Leyseele has been the CEO of the company since 2019. | Director/Board Member | 2020-05-27 |
Former positions of Gerardus Johannes van Jeveren
Companies | Position | End |
---|---|---|
FAGRON N.V. | Chief Executive Officer | 2015-11-29 |
OMEGA PHARMA | Corporate Officer/Principal | 2004-12-31 |
Fagron Group BV
Fagron Group BV Pharmaceuticals: MajorHealth Technology Part of Fagron NV, Fagron Group BV is a Dutch pharmaceutical company that manufactures pharmaceutical products. The company is based in Nieuwerkerk aan den Ijssel, Netherlands. The company was founded by Gerardus Johannes van Jeveren. | Founder | - |
Pharbita Generics | Sales & Marketing | - |
Training of Gerardus Johannes van Jeveren
Lerarenopleiding Zuid West Nederland | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
FAGRON N.V. | Distribution Services |
Private companies | 5 |
---|---|
Omega Pharma NV
Omega Pharma NV Pharmaceuticals: MajorHealth Technology Omega Pharma NV engages in the manufacture and distribution of pharmaceutical products. It offers prescription medicines, health products, and cosmetics. The company was founded by Marc Coucke in 1987 and is headquartered in Nazareth, Belgium. | Health Technology |
Fagron Group BV
Fagron Group BV Pharmaceuticals: MajorHealth Technology Part of Fagron NV, Fagron Group BV is a Dutch pharmaceutical company that manufactures pharmaceutical products. The company is based in Nieuwerkerk aan den Ijssel, Netherlands. The company was founded by Gerardus Johannes van Jeveren. | Health Technology |
Pharbita Generics | |
Fagron GmbH & Co. KG
Fagron GmbH & Co. KG Pharmaceuticals: MajorHealth Technology Fagron GmbH & Co. KG develops and manufactures pharmaceutical products. Its brands include SyrSpend SF, Fitalite, Versatile, Versatile Rich, Nourivan Antiox, Espumil, Latanoprost, Pentravan Transdermale, and CapsiCards System. It also offers pharmaceutical solutions for pharmacies, hospitals, and clinics. The company was founded by Gerardus Johannes van Jeveren in 1990 and is headquartered in Barsbüttel, Germany. | Health Technology |
Pharma Chemicals SA
Pharma Chemicals SA Pharmaceuticals: MajorHealth Technology Pharma Chemicals SA manufactures pharmaceutical products. The private company is based in Braine-le-Château, Belgium. The Belgian company was founded in 2016. Tieme Leyseele has been the CEO of the company since 2019. | Health Technology |
- Stock Market
- Insiders
- Gerardus Johannes van Jeveren